Dr. Douer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-2471
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1981- The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1976
Certifications & Licensure
- CA State Medical License 1980 - 2026
- NY State Medical License 2011 - 2018
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Intensified Post Remission Therapy Containing PEG-Asparaginase Start of enrollment: 2004 Jul 01
- Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia Start of enrollment: 2002 Apr 01
- New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia Start of enrollment: 2010 May 01
- Join now to see all
Publications & Presentations
PubMed
- Recognition, prevention, and management of adverse events associated with asparaginase / pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of...Emily Curran, Marlise R Luskin, Houda Alachkar, Ibrahim Aldoss, Patrick W Burke
Haematologica. 2025-03-20 - 1 citationsDelaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impact...Jose Tinajero, Sharon Xu, Dat Ngo, Shanpeng Li, Joycelynne Palmer
British Journal of Haematology. 2025-03-01 - 3 citationsAsparaginase: How to Better Manage Toxicities in Adults.Hoda Pourhassan, Dan Douer, Vinod Pullarkat, Ibrahim Aldoss
Current Oncology Reports. 2023-01-01
Grant Support
- Il-12-Faciliated Hematopoietic Recovery Following Myeloablative TherapyNational Cancer Institute2007
- Uses Of IL-12 As A Hematological Adjuvant Cancer TherapyNational Cancer Institute2006
- Arsenic Trioxide And Vitamin C In AMLNational Cancer Institute2004–2005
- Uses Of IL-12 As A Hematological Adjuvant Cancer TherapyNational Cancer Institute2004
- Compassionate Use Of Arsenic Trioxide In Relapsed Acute Promyelocytic LeukemiaNational Center For Research Resources2000
Professional Memberships
- Member
- Member
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
